Loading
Latest filing published 02 Jun 2026 for Medicenna Therapeutics Corp., €4,039. Read the official filing
Angelos Georgakis appears in our data through filings on Medicenna Therapeutics Corp. shares, published by SEDI. Between 12 February 2026 and 28 May 2026, the trades on record add up to 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 2 June 2026, the filings show a transaction worth €4,039 in Medicenna Therapeutics Corp. Filings reach the SEDI feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations